ATOSSA THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.5M | $-9.6M | $-8.7M | $-8.4M | $-6.7M | $-7.2M | $-6.0M | $-5.9M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | $4.0K | — | — | $4.0K | — | — | $5.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $722.0K | — | — | $563.0K | — | — | $417.0K |
| Net Cash from Operating Activities | $-9.6M | $-9.6M | $-6.0M | $-7.3M | $-6.0M | $-4.8M | $-4.5M | $-4.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $7.0K | $0 | $9.0K | $10.0K | $3.0K | $6.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $0 | — | — | $-9.0K | — | — | $-6.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $0 | — | — | $0 | — | — | $204.0K |
| Net Change in Cash | — | $-9.6M | — | — | $-6.0M | — | — | $-4.5M |
| Free Cash Flow | $-9.6M | $-9.6M | $-6.0M | $-7.3M | $-6.0M | $-4.8M | $-4.5M | $-4.7M |